Skip Navigation

Search

13 results found

Search Options

13 results found

Order By

Filter By

Information Type
Geographic Coverage
Publication Release
Find
Publication Coverage
From:
To:
Find
Prescribing Costs in Hospitals and the Community, England 2016/17

Published: 21 November 2017 - This report presents summary figures relating to medicine costs at list price in hospitals and in the community in England for 2016/17, and the recent growth in use. The report aims to show the relative use of medicines in hospital and in primary care and the wider health economy. It also includes a section looking at the costs at list price of medicines positively appraised by NICE. Many of these are used mainly or exclusively in hospitals.

Prescribing Costs in Hospitals and the Community, England 2015/16

This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE. £ All costs given in this report are net ingredient cost (NIC). This is the basic price of a drug excluding VAT (the price listed in the national Drug Tariff or in standard price lists). Cost changes have not been adjusted for inflation. It does not take account of discounts, dispensing costs, fees or prescription charges income. £ Please note, the key fact figure£for the rise in the cost of medicines in hospitals since 2010/11 has been corrected to 81.8 per cent as£stated in the accompanying report.

Prescribing Costs in Hospitals and the Community, England 2014-15

This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.

Hospital Prescribing: England, 2013-14

This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE. On 14 November 2014, an additional Excel file was made available, containing the underlying data from all the Tables and Figures in the report.

Hospital Prescribing, England - 2012

Please note: on 26 November 2013 an updated version of the report was uploaded to correct an error in the data presented for England in Table 3 of the report. All SHA figures in this table were correct and remain the same. This was due to a production error by the HSCIC. This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year are anti-bacterial drugs (BNF Section 5.1).

Hospital Prescribing - England, 2011

This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year£is£medicines for HIV and AIDs. £ An error has been identified with the figures given in table 4 for alendronic acid and rosiglitazone in the original publication released in November 2012. Corrected versions of the report and the Excel spreadsheet replaced the incorrect versions on 25th March 2013

Hospital Prescribing - England, 2010

This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. Specific areas covered this year are ADHD, psychosis and anti-TNF medicines.

Hospital Prescribing - England, 2009

This report describes use of drugs in hospitals in England in 2009. In order to put this use in context it also shows use in primary care and where a prescription was written in hospital but dispensed in the community.

Hospital Prescribing - England, 2008

The bulletin details expenditure on drugs in hospitals in England setting it in the context of overall drug expenditure. There is also a table focussing on drugs positively appraised by NICE and comparing use of "low-cost" drugs between SHAs.

Hospital Prescribing - England, 2007

This bulletin reports on use of medicines in primary care, in hospitals and those prescribed in hospitals, but dispensed in the community. Costs for hospital use are provided by IMS Health who collect volume data from a large sample of hospitals and cost this using the Drug Tariff and standard price lists. This means that the costs are not necessarily what the hospitals paid as they are often able to negotiate a discount. The data for the other two sectors comes from the Prescription Pricing Division of the Business Services Authority who is responsible for reimbursing those who dispense prescriptions.

Have a question? Call us on 0300 303 5678 or contact enquiries@nhsdigital.nhs.uk.

Tell us what you think of the new website beta.

We use cookies to provide you with a better service. Carry on browsing if you're happy with this, or find out how to manage cookies. Find out more